• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [20001 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2018     European Network for Health Technology Assessment (EUnetHTA) Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2013     Technology Assessment Unit of the McGill University Health Centre (MUHC) Transcatheter aortic valve implantation (TAVI) in patients with aortic stenosis. Update of Report No. 45
2021     Norwegian Institute of Public Health (NIPH) Transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical risk groups: a health technology assessment
2011     Belgian Health Care Knowledge Centre (KCE) Transcatheter aortic valve implantation (TAVI): an updated health technology assessment
2012     HAYES, Inc. Transcatheter aortic valve implantation for aortic stenosis
2013     HAYES, Inc. Transcatheter aortic valve implantation for aortic stenosis
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve implantation for aortic stenosis: a review of the clinical effectiveness and guidelines
2013     Health Quality Ontario (HQO) Transcatheter aortic valve implantation for the treatment of aortic valve stenosis: an evidence update
2016     Health Quality Ontario (HQO) Transcatheter aortic valve implantation for treatment of aortic valve stenosis: a health technology assessment
2016     Health Quality Ontario (HQO) Transcatheter aortic valve implantation for treatment of aortic valve stenosis: OHTAC recommendation
2020     Ontario Health Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk
2020     Ontario Health Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment
2015     Medical Services Advisory Committee (MSAC) Transcatheter aortic valve implantation via transfemoral or transapical delivery
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve implantation: a critical appraisal of a health technology assessment and comparison with a rapid review
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve replacement
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve replacement in severe aortic stenosis: a review of comparative durability and clinical effectiveness beyond 12 months
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve replacement in severe aortic stenosis: a review of comparative durability and clinical effectiveness beyond 12 months
2006     Haute Autorite de sante (HAS) Transcatheter closure of a patent foramen ovale
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Transcatheter closure of atrial septal defects
2013     Medical Services Advisory Committee (MSAC) Transcatheter closure of patent ductus arteriosus
2017     HAYES, Inc. Transcatheter closure of prosthetic aortic or mitral paravalvular leaks
2002     HAYES, Inc. Transcatheter closure of septal defects
2008     HAYES, Inc. Transcatheter closure of ventricular septal defects
2010     National Institute for Health and Clinical Excellence (NICE) Transcatheter endovascular closure of perimembranous ventricular septal defect
2016     Agenzia nazionale per i servizi sanitari regionali (Agenas) Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation
2021     Agency for Care Effectiveness (ACE) Transcatheter mitral valve leaflet repair for patients with mitral regurgitation
2014     Medical Services Advisory Committee (MSAC) Transcatheter occlusion of the left atrial appendage (LAA) for patients with non-valvular atrial fibrillation
2015     HAYES, Inc. Transcatheter surgical valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for aortic stenosis
2022     Ontario Health Transcatheter valve-in-valve implantation for degenerated mitral or tricuspid bioprosthetic valves: a health technology assessment
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcendental meditation for posttraumatic stress disorder, depression, and anxiety: a review of clinical effectiveness
2007     HAYES, Inc. Transconjunctival sutureless vitrectomy using the Millennium TSV25 system (Bausch&Lomb Inc.)
2009     NIHR Horizon Scanning Centre (NIHR HSC) Transcranial direct current stimulation (tDCS) for Alzheimer's disease
2009     NIHR Horizon Scanning Centre (NIHR HSC) Transcranial direct current stimulation (tDCS) for major depressive disorder
2017     HAYES, Inc. Transcranial direct current stimulation for depression
2014     HAYES, Inc. Transcranial direct current stimulation for depression
2013     Malaysian Health Technology Assessment (MaHTAS) Transcranial Doppler (TCD) ultrasound and cerebral computed tomography perfusion (CTP) for aneurysmal subarachnoid haemorrhage (SAH)
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Transcranial doppler ultrasonography: main clinical applications
2015     The Regional Health Technology Assessment Centre (HTA-centrum) Transcranial Magnetic Resonance Guided Focused Ultrasound treatment of essential tremor, neuropathic pain and Parkinson's disease
2016     Adelaide Health Technology Assessment (AHTA) Transcranial magnetic resonance-guided focused ultrasound and deep brain stimulation for refractory depression
2010     VA Technology Assessment Program (VATAP) Transcranial magnetic stimulation (TMS) for depression
2014     HAYES, Inc. Transcranial Magnetic Stimulation (TMS) to enhance pharmacotherapy for depression
2011     Blue Cross Blue Shield Association (BCBS) Transcranial magnetic stimulation for depression
2009     Blue Cross Blue Shield Association (BCBS) Transcranial magnetic stimulation for depression
2014     Blue Cross Blue Shield Association (BCBS) Transcranial magnetic stimulation for depression
2007     HAYES, Inc. Transcranial magnetic stimulation for major depression
2010     HAYES, Inc. Transcranial magnetic stimulation for major depression
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcranial magnetic stimulation for the treatment of adults with PTSD, GAD, or depression: a review of clinical effectiveness and guidelines
2021     Health Technology Wales (HTW) Transcranial magnetic stimulation for the treatment of depression
2011     Blue Cross Blue Shield Association (BCBS) Transcranial magnetic stimulation for the treatment of schizophrenia
2014     HAYES, Inc. Transcranial magnetic stimulation for treatment-resistant depression
2008     Health Council of the Netherlands Gezondheidsraad (GR) Transcranial magnetic stimulation in psychiatry and neurology
2001     Norwegian Knowledge Centre for the Health Services (NOKC) Transcranial magnetic stimulation in the treatment of depressions
2012     HAYES, Inc. Transcription Factor 4 (TCF4) testing for Pitt-Hopkins Syndrome (PTHS)
2010     HAYES, Inc. Transcutaneous bilirubin measurement
2013     Institute of Health Economics (IHE) Transcutaneous bilirubinometry for the screening of neonatal hyperbilirubinemia ≥35 weeks' gestation
2000     Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) Transcutaneous bilirubinometry in the context of early postnatal discharge
2001     VA Technology Assessment Program (VATAP) Transcutaneous Electrical Nerve Stimulation
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Transcutaneous electrical nerve stimulation (TENS-PENS) for back pain
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Transcutaneous electrical nerve stimulation (TENS-PENS) for back pain
2006     HAYES, Inc. Transcutaneous electrical nerve stimulation (TENS) for the treatment of nausea and vomiting
1995     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Transcutaneous electrical nerve stimulation and pain management - nonsystematic review
2010     HAYES, Inc. Transcutaneous electrical nerve stimulation for postoperative and procedural pain
2000     HAYES, Inc. Transcutaneous electrical nerve stimulation for the treatment of pain
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Transdermal contraceptive patch - a new birth control option
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Transdermal hormone replacement therapy patches for women with postmenopausal symptoms: economic analysis of short-term use
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Transdermally-delivered oxybutynin (Oxytrol(R)) for overactive bladder
2002     Blue Cross Blue Shield Association (BCBS) Transesophageal endoscopic treatments for gastroesophageal reflux disease
2004     Blue Cross Blue Shield Association (BCBS) Transesophageal endoscopic treatments for gastroesophageal reflux disease
2012     Center for Evidence-based Practice (CEP) Transfer of neurointensive care patients
1996     VA Technology Assessment Program (VATAP) Transferring managed care principles to VHA
2016     NIHR Health Services and Delivery Research programme Transforming community health services for children and young people who are ill: a quasi-experimental evaluation
2005     Norwegian Knowledge Centre for the Health Services (NOKC) Transfusion and alternative treatment in acute haemorrhage
2010     Center for Evidence-based Practice (CEP) Transfusion thresholds for cardiovascular surgery patients
2010     Center for Evidence-based Practice (CEP) Transfusion thresholds for orthopedic surgery patients
2016     Center for Evidence-based Practice (CEP) Transfusion thresholds in cardiovascular surgery
2004     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Transhiatal oesophageal resection without thoracotomyversus transthoracic oesophageal resection with two-field lymph gland- primary research
2008     NIHR Horizon Scanning Centre (NIHR HSC) Transient elastography (FibroScan) for evaluating liver fibrosis
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Transient elastography (FibroScan) for non-invasive assessment of liver fibrosis
2015     Health Quality Ontario (HQO) Transient elastography and controlled attenuation parameter for diagnosing liver fibrosis and steatosis in Ontario: an economic analysis
2015     Health Quality Ontario (HQO) Transient elastography for assessment of liver fibrosis and steatosis: an evidence-based analysis
2015     Health Quality Ontario (HQO) Transient elastography for assessment of liver fibrosis and steatosis: OHTAC recommendation
2013     Health Quality Ontario (HQO) Transient ischemic attack: where can patients receive optimal care? A rapid review
2002     HAYES, Inc. Transilluminated powered phlebectomy for symptomatic varicose veins
2004     National Institute for Clinical Excellence (NICE) Transilluminated powered phlebectomy for varicose veins
2014     Agency for Healthcare Research and Quality (AHRQ) Transition care for children with special health needs
2011     Agency for Healthcare Research and Quality (AHRQ) Transition of care for acute stroke and myocardial infarction patients: from hospitalization to rehabilitation, recovery, and secondary prevention
2014     Agency for Healthcare Research and Quality (AHRQ) Transitional care interventions to prevent readmissions for people with heart failure
2014     NIHR Health Services and Delivery Research programme Transitions at the end of life for older adults - patient, carer and professional perspectives: a mixed-methods study
2013     NIHR Health Services and Delivery Research programme Transitions to palliative care for older people in acute hospitals: a mixed-methods study
1996     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Transjugular intrahepatic porto-systemic shunt - systematic review, expert panel, primary research
2018     Center for Evidence-based Practice (CEP) Transjugular Intrahepatic Portosystemic Shunts for Patients with Acute Variceal Bleeding
2015     NIHR Health Services and Delivery Research programme Translation into British Sign Language and validation of the Strengths and Difficulties Questionnaire
1995     NIHR Health Technology Assessment programme Translation of Spanish report on routine pre-operative testing
2003     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Transluminal dilatation for symptomatic atheromatous stenosis of the carotid bifurcation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Transmission of infectious agents and risk of injury from patient transfer boards in healthcare settings: clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Transmission of infectious agents from magazines, books, and toys in healthcare settings: clinical evidence and guidelines
2020     Center for Evidence-based Practice (CEP) Transmission of respiratory infections via showers
1999     Medical Services Advisory Committee (MSAC) Transmyocardial laser revascularisation
2002     HAYES, Inc. Transmyocardial laser revascularization